97%
77%
94%
Source: Provided by San Francisco Department of Public Health
97%
75%
70%
Source: Provided by San Francisco Department of Public Health
Community Health Equity & Promotion Branch (CHEP)
Population Health Division
San Francisco Department of Public Health
CHEP provides and supports HIV-related services including testing, linkage to care, partner services, education, and condom and clean needle distribution. CHEP also works with the HIV Prevention Planning Council and other community members on program development. In addition, CHEP also conducts program evaluation, works on strategy response, and provides funding, technical assistance, education, and training to partner organizations. (via www.sfhiv.org)
Susan Buchbinder : Bridge HIV
Director, MD
25 Van Ness Avenue, Suite 100 San Francisco, CA 94102
(415) 437-7400
Bridge HIV has been at the vanguard of HIV prevention science since the beginning of the HIV epidemic and is a recognized global leader in HIV prevention research, working with local and international communities to discover effective ways to prevent HIV. This branch works with local and international scientists and communities to discover effective HIV prevention strategies through research, community partnerships, and educational initiatives. Operating as a clinical trials unit (CTU) within the San Francisco Department of Public Health and affiliated with the University of California, San Francisco (UCSF), Bridge HIV conducts innovative research that guides global approaches to prevent HIV and AIDS. Bridge HIV’s work is funded by the National Institute of Allergy and Infectious Diseases (NIAID) a division of the National Institutes of Health (NIH). NIAID supports six clinical trials networks that conduct domestic and international human studies focused on the Institute’s highest HIV/AIDS research priorities. Bridge HIV participates in three of the networks: HIV Prevention Trials Network (HPTN); HIV Vaccine Trials Network (HVTN); and the Microbicide Trials Network (MTN).
Willi McFarland : Center for Public Health Research
Director, MD, PhD, MPH
25 Van Ness Avenue, Suite 500 San Francisco, CA 94102
(415) 437-6200
This branch provides expertise in epidemiology, clinical trials, evaluations, and implementation science research. The focus has been on substance use and HIV, but the branch also assesses and addresses other infectious diseases including viral hepatitis, sexually transmitted infections, diarrhea, malaria, and other pathogens affecting San Francisco and marginalized populations globally. The branch provides SFDPH and its partner’s technical training, consultation, expertise, and oversight in population survey design, questionnaire development, data collection modalities, statistical methods, GIS mapping, the conduct of clinical trials, and implementation science.
Susan Philip : Disease Prevention & Control
Director, MD, MPH
1360 Mission Street, Suite 401 San Francisco, CA 94103
(415) 355-2007
This branch integrates the core public health communicable disease functions, along with specialty care & treatment, and laboratory diagnostics. The goal is to find opportunities to increase capacity, align services, and deliver effective and efficient services at the client and community level. This branch is responsible for interacting with SFDPH Health Delivery Systems in order to coordinate and maximize disease screening and other prevention activities in primary care and the hospitals.
Dr. Grant Colfax: San Francisco Department of Public Health
Director of Health
Patricia Erwin
Action Director of CHEP
30 Van Ness, Suite 2300, San Francisco, CA 94102
(415) 581-2400
Ling Hsu : Applied Research, Community Health Epidemiology, & Surveillance (ARCHES)
Director, PhD
25 Van Ness Avenue, Suite 500 San Francisco, CA 94102
This branch coordinates data collection, processing, management, analysis and interpretation related to health and morbidity in San Francisco. Working with private and public clinics, community based organizations, outreach, research, and the laboratories, ARCHES maintains systems to gather, explore, analyze, and present data to inform decision-making to maximize public health. Data across conditions, populations, and health status are integrated to assess and help solve community health problems; diagnose and investigate health problems and health hazards in the community; evaluate effectiveness of interventions and services, and monitor quality.
"People ask us what the ‘special sauce’ is that accounts for San Francisco’s success against HIV. It’s the full engagement of all segments of society -- activists, providers, researchers, and the SF government – all working toward a common goal."
"Boldness’ means we speak up in the face of doubt and adversity. We did that in the 1980s, when the HIV epidemic first appeared. We did that in 2010, when we were the first to recommend treatment for all persons living with HIV. We’re doing it now, with the current research and studies we have toward finding a cure, with vaccine research, and being at the forefront of PrEP."
“San Francisco’s accomplishments in the battle against HIV are the result of passion, community activism, scientific expertise, partnership and persistence. We started more than 30 years ago when the AIDS epidemic began, and have been world leaders in research, care and prevention. Now we must continue to work together to focus on equity in order to cross the finish line and get to zero.”
"It is a privilege to be a member of the San Francisco Getting To Zero (GTZ) Steering Committee as a representative of our city’s HIV Community Planning Council (HCPC). Because the mission(s) of both these entities are so complementary, ensuring an effective and meaningful partnership between these two critical planning bodies is necessary and vital if we are to see an integrated and effective system of HIV prevention and care for all San Franciscans, especially those either at-risk for or those living with HIV.”
"We don't believe in doing things top-down here," said Scott Weiner, a member of the city's Board of Supervisors or city council. "The reason San Francisco has had so much success is not because city government saying 'this is what we’re going to do,' but because of an amazing coalition of community-based advocates."
“San Francisco has always lead the way in the fight against HIV. We established an internationally recognized model of care for AIDS during the height of the epidemic in the 1980s and 1990s and we have continued to innovate and save lives in the decades since. While we have made tremendous progress toward Getting to Zero new HIV infections in San Francisco, our most vulnerable residents, including those living on our streets, remain at risk. The end of HIV is in sight, and it’s time for San Francisco to get across the finish line and Get to Zero.”
"I'm involved with Getting To Zero because achieving the three goals of GTZ will save and transform the lives of thousands of San Franciscans."
"Getting to Zero is also a call to action for health equity in HIV prevention, care, and treatment for all of our communities."
